Schizophrenia Clinical Trials in Omaha, Nebraska

3 studies are recruiting for schizophrenia in Omaha, Nebraska right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

    This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Neurocrine Clinical Site, Omaha, Nebraska
    Locations
    19 in total
    Run by
    Neurocrine Biosciences

    See if you can join NCT07105111 on ClinicalTrials.gov

  2. Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

    The purpose of this study is to understand treatment preference and satisfaction among adults with schizophrenia in the United States who are prescribed xanomeline and trospium chloride (X/T) therapy

    Stage
    Not phased
    Ages
    18 and older
    Site
    Omaha Insomnia and Psychiatric Services, Omaha, Nebraska
    Locations
    20 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT07101094 on ClinicalTrials.gov

  3. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Alkermes Investigator Site, Omaha, Nebraska
    Locations
    47 in total
    Run by
    Alkermes, Inc.

    See if you can join NCT05303064 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.